Amylee Amos, MS, RDN interviews Dr. Dale Bredesen Discussion on: Alzheimer's, Parkenson, LewyBody, ALS, & Macular Degeneration. Plus: Latest research? How does the Bredesen Protocol treat Alzheimer’s? Why aren't current medicines effective? How do our genetics affect whether we get Alzheimer's Disease? How can the Amos Institute help people with the Bredesen Protocol? Latest results of the Bredesen Protocol? Does the Bredesen Protocol work for prevention?
Mar 31, 2019
Promising research into the disease shows the possibility of prevention and even reversal of cognitive decline. There may be multiple risk factors for Alzheimer’s, such as chronic inflammation, chronic infections, tick-borne illnesses, the presence of the ApoE4 gene, mold or heavy metals toxicity, hormone changes, and others. Getting a “cognoscopy” at age 45 could give early warning indicators. Prevention protocols may vary widely amongst individuals.
Published Mar 18, 2019
In this episode we discuss the revolutionary new research being done in the field of Alzheimer's Disease and how we are finally offering patients and families afflicted with this devastating disease new treatments using a combination of the ReCODE protocol from Dr. Dale Bredesen and our own work.
Published on Jul 3, 2018
In this episode we wrap up our discussion of recent advancements in Alzheimer's disease with an overview of how we can accurately detect contributors to this inflammatory disease of the brain perhaps before any long term damage has occurred. Our efforts in the medical community to PREVENT this disease must continue if we are to find effective solutions to this debilitating epidemic.
Published on Oct 9, 2018
In this episode, our founder and functional medicine pioneer, Elroy Vojdani, MD, IFMCP and his father, Dr. Aristo Vojdani, discuss the advancements being made in Alzheimer’s disease with Dr. Bredesen. Part of Dr. Bredesen’s work in the field has resulted in the creation of a highly respected treatment program named the Bredesen ReCODE Protocol. Our founder, Dr. V, is a certified Bredesen ReCODE Practitioner. They also discuss aluminum and plastics.
Published on Apr 1, 2019
"I have begun work with close to 30 patients for either prevention or reversal of cognitive decline. I have learned many things along the way, and have streamlined my approach, introduced practices to make it more comprehensive, as well as interventions to get to the root cause of the dysfunctions that lead to cognitive decline."
-Dr. Myrto Ashe
Dale Bredesen, MD, UCSF and UCLA, discusses how environmental toxins may lead to Alzheimers disease. Recorded on 09/21/2018. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment"
Published on Oct 10, 2018
Robert Sheeler, M.D. is a Board Certified Physician who spent 22 years at Mayo Clinic in Rochester, MN. * Board Certified in Integrative Medicine and Urgent Care * Certified in Functional Medicine and a sub-specialist in Headache Medicine
Ankit Chander, M.D. is a primary care physician and Diplomate of the American Board of Integrative Holistic Medicine. * Graduate - Johns Hopkins University School of Medicine
Published on Jan 9, 2018
Charmaine Shepherd and Jean Dow, Clinic Directors at CogMission in Edinburgh, Scotland talk about their training on the Bredesen Protocol and early success with an Alzheimer's patient.
Published on Jun 29, 2018
Carol Grieve' of Food Integrity Now interviews Dr. Dale Bredesen about his new book, The End of Alzheimer's, The First Program to Prevent and Reverse Cognitive Decline. Carol Grieve' is the Founder, CEO and host of Food Integrity Now. She is a Certified Holistic Nutritionist using the functional medicine process, life coach, food educator, speaker, writer, visionary and artist.
Published on Aug 25, 2018
The story of returning from the grip of dementia as told by the patient and her caregiver. Don't believe it can be done? Read the MEND research study on Alzheimer's. Thank you Dr Bredesen of UCLA for your research validating this work.
Published on Sep 27, 2015
Video interview with Dr. Dale Bredesen of Mary S. Easton Center for Alzheimer's Disease Research, Department of Neurology, University of California, Los Angeles, CA and the Buck Institute for Research on Aging, Novato, CA talking about their featured cover paper in Aging (Albany, NY) Volume 6 Issue 9 - "Reversal of cognitive decline: A novel therapeutic program" http://bit.ly/2jQuIx7
Published on Mar 12, 2017
Sign up to hear from us about specials, sales, and events.